What Has 30 Years of HIV Vaccine Research Taught Us?
AbstractWhen HIV was discovered and established as the cause of AIDS in 1983–1984, many people believed that a vaccine would be rapidly developed. However, 30 years have passed and we are still struggling to develop an elusive vaccine. In trying to achieve that goal, different scientific paradigms have been explored. Although major progress has been made in understanding the scientific basis for HIV vaccine development, efficacy trials have been critical in moving the field forward. Major lessons learned are: the development of an HIV vaccine is an extremely difficult challenge; the temptation of just following the fashion should be avoided; clinical trials are critical, especially large-scale efficacy trials; HIV vaccine research will require long-term commitment; and sustainable collaborations are needed to accelerate the development of an HIV vaccine. Concrete actions must be implemented with the sense of urgency imposed by the severity of the AIDS epidemic.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Esparza, J. What Has 30 Years of HIV Vaccine Research Taught Us? Vaccines 2013, 1, 513-526.
Esparza J. What Has 30 Years of HIV Vaccine Research Taught Us? Vaccines. 2013; 1(4):513-526.Chicago/Turabian Style
Esparza, José. 2013. "What Has 30 Years of HIV Vaccine Research Taught Us?" Vaccines 1, no. 4: 513-526.